EEF1DP3
Putative elongation factor 1-delta-like protein
Also known as: EF1DL_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for EEF1DP3 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
133 residues, UniProt reviewed canonical sequence.
>Q658K8|EEF1DP3
1 MATNFLVGEK IWFHKFKYGD AERRFYEQMN GPVAGASLQE ASMILHDIAR ARENIPKSLA
61 GSLGPGASSG PSGDHSELVV RIASLEVDNQ RDLAERAGEE LARPLGHSPA DPAHVSHAPS
121 GAPGQEASHT SRGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EEF1DP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EEF1DP3 as an antibody target. Whether an autoantibody or antibody against EEF1DP3 could matter depends on whether native EEF1DP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EEF1DP3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EEF1DP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...